79 related articles for article (PubMed ID: 33607580)
1. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
Lim Z; Gu TY; Tai BC; Puhaindran ME
World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
[TBL] [Abstract][Full Text] [Related]
3. A case report of giant malignant schwannoma of the sciatic nerve associated with neurofibromatosis-1: A CARE-compliant article.
Gokkus K; Saylik M; Birtay T; Sahin MS
Medicine (Baltimore); 2023 Nov; 102(47):e36358. PubMed ID: 38013269
[TBL] [Abstract][Full Text] [Related]
4. Surgical management of craniospinal axis malignant peripheral nerve sheath tumors: a single-institution experience and literature review.
Chowdhury A; Vivanco-Suarez J; Teferi N; Belzer A; Al-Kaylani H; Challa M; Lee S; Buatti JM; Hitchon P
World J Surg Oncol; 2023 Oct; 21(1):338. PubMed ID: 37880773
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 promotes neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor progression in a NUF2-dependent manner.
Aimaier R; Chung MH; Gu Y; Yu Q; Wei C; Li H; Guo Z; Long M; Li Y; Wang W; Li Q; Wang Z
Cancer Gene Ther; 2023 Oct; 30(10):1390-1402. PubMed ID: 37488294
[TBL] [Abstract][Full Text] [Related]
6. FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Voigt E; Quelle DE
Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686402
[TBL] [Abstract][Full Text] [Related]
7. Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy.
Bhandarkar AR; Bhandarkar S; Babovic-Vuksanovic D; Parney IF; Spinner RJ
J Neurooncol; 2023 Sep; 164(3):693-699. PubMed ID: 37755632
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumor in the Nasal Cavity.
Marini K; Skliris JP; Garefis K; Skitotomidou E; Argyriou N
Cureus; 2023 Sep; 15(9):e45175. PubMed ID: 37842475
[TBL] [Abstract][Full Text] [Related]
9. Synchronous Development of Multicentric Malignant Peripheral Nerve Sheath Tumors: Institutional Review.
Peters PA; Kaszuba MC; Raghunathan A; Puffer RC; Spinner RJ
World Neurosurg; 2018 Dec; ():. PubMed ID: 30597282
[TBL] [Abstract][Full Text] [Related]
10. Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor.
Turner-Ivey B; Longo JF; Jenkins DP; Guest ST; Carroll SL
J Vis Exp; 2023 Aug; (198):. PubMed ID: 37677047
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the Peripheral Nerve in Neurofibromatosis Type 1.
Staedtke V; Bai RY; Blakeley JO
Neurotherapeutics; 2017 Apr; 14(2):298-306. PubMed ID: 28349408
[TBL] [Abstract][Full Text] [Related]
12. Bulky malignant peripheral nerve sheath tumour of the left thigh in a pregnant woman presenting with a pathological fracture of the proximal femur.
Catelas D; Sousa D; Rodrigues AP; Cardoso P
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569727
[TBL] [Abstract][Full Text] [Related]
13. Malignant peripheral nerve sheath tumor of the uterine cervix: A case report and literature review.
Liu X; Li L
Oncol Lett; 2024 Feb; 27(2):68. PubMed ID: 38192675
[TBL] [Abstract][Full Text] [Related]
14. Intracranial malignant peripheral nerve sheath tumor: A case report and comprehensive literature review.
Wilkinson BM; Duncan MA; Davila R; Nicholas B; Babu H
Surg Neurol Int; 2024; 15():101. PubMed ID: 38628513
[TBL] [Abstract][Full Text] [Related]
15. An intraosseous malignant peripheral nerve sheath tumor of the lumbar spine without neurofibromatosis: Case report and review of the literature.
Suzuki K; Yasuda T; Hori T; Watanabe K; Kanamori M; Kimura T
Oncol Lett; 2014 Jun; 7(6):1965-1969. PubMed ID: 24932270
[TBL] [Abstract][Full Text] [Related]
16. Metastatic malignant peripheral nerve sheath tumour in a patient with neurofibromatosis 1 and review of contemporary systemic treatments.
Hones K; Krekora U; Nasri E; Altshuler E
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36192032
[TBL] [Abstract][Full Text] [Related]
17. MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors.
Payne R; Mrowczynski OD; Slagle-Webb B; Bourcier A; Mau C; Aregawi D; Madhankumar AB; Lee SY; Harbaugh K; Connor J; Rizk EB
J Neurosurg; 2018 Feb; 130(2):465-475. PubMed ID: 29473773
[TBL] [Abstract][Full Text] [Related]
18. Factors of influence upon overall survival in the treatment of intracranial MPNSTs. Review of the literature and report of a case.
Gousias K; Boström J; Kovacs A; Niehusmann P; Wagner I; Kristof R
Radiat Oncol; 2010 Nov; 5():114. PubMed ID: 21106096
[TBL] [Abstract][Full Text] [Related]
19. Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors.
Zhang L; Lemberg KM; Calizo A; Varadhan R; Siegel AH; Meyer CF; Blakeley JO; Pratilas CA
Neurooncol Adv; 2023; 5(1):vdad156. PubMed ID: 38130899
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study on subcutaneous malignant peripheral nerve sheath tumors in 14 domestic rabbits (Oryctolagus cuniculus) treated surgically between 2008 and 2021.
Wu CC; Miwa Y; Nakata M; Chambers JK; Uchida K; Sasaki N
J Vet Med Sci; 2024 Jan; 86(1):66-70. PubMed ID: 37952973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
